PCMTD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.60689997261454E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.36370000000253E-05 |
Normal-vs-Stage2 |
3.614200E-02 |
Normal-vs-Stage3 |
1.0434000330406E-09 |
Normal-vs-Stage4 |
1.67410529883227E-12 |
Stage1-vs-Stage2 |
9.927400E-01 |
Stage1-vs-Stage3 |
2.364600E-03 |
Stage1-vs-Stage4 |
1.10080000004231E-07 |
Stage2-vs-Stage3 |
1.007020E-01 |
Stage2-vs-Stage4 |
5.083900E-03 |
Stage3-vs-Stage4 |
5.181700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.29750005079177E-09 |
Normal-vs-AfricanAmerican |
3.616500E-03 |
Normal-vs-Asian |
3.542800E-01 |
Caucasian-vs-AfricanAmerican |
6.049600E-01 |
Caucasian-vs-Asian |
3.404400E-01 |
AfricanAmerican-vs-Asian |
5.301600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.14660003292767E-09 |
Normal-vs-Female |
5.23259999996029E-07 |
Male-vs-Female |
6.837400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.336480E-02 |
Normal-vs-Age(41-60Yrs) |
1.92210000005133E-06 |
Normal-vs-Age(61-80Yrs) |
4.42439995751442E-09 |
Normal-vs-Age(81-100Yrs) |
4.29299999999966E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.470200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.456400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.717400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.330400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.261600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.773000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.091000E-01 |
Normal-vs-Grade 2 |
1.064010E-02 |
Normal-vs-Grade 3 |
2.89057666691406E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
1.675760E-01 |
Grade 1-vs-Grade 3 |
3.63469999999921E-05 |
Grade 1-vs-Grade 4 |
7.18340054106648E-10 |
Grade 2-vs-Grade 3 |
6.13470000021543E-07 |
Grade 2-vs-Grade 4 |
3.33066907387547E-16 |
Grade 3-vs-Grade 4 |
3.97380000016767E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.946000E-02 |
Normal-vs-ccB subtype |
3.44849704347894E-11 |
ccA subtype-vs-ccB subtype |
1.40100000045607E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.52979999463221E-08 |
Normal-vs-N1 |
2.97360003287395E-09 |
N0-vs-N1 |
9.804900E-03 |
|
|